Featured post
Canada
Clinical Trials
News
FOLFIRINOX
Checkpoint Inhibitor
Artifical Intelligence
Early Detection
Immunotherapy
Artifical Intelligence
Artificial intelligence (AI) is transforming pancreatic cancer research, from improving early detection to advancing drug discovery and clinical trial matching. AI is being used to analyze tumors at a molecular level, predict treatment responses, and speed up research. This collection explores how AI is shaping the future of pancreatic cancer care, the latest breakthroughs, and what these innovations mean for Canadians living with pancreatic cancer.
